Marco Antonio Montes-Cano

Dr. Marco Antonio Montes-Cano

Servicio de Inmunología, Hospital Universitario Virgen del Rocío, Sevilla, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2013 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
MMMarco Antonio Montes-Cano
Marco Antonio Montes-Cano
MCMarta Conde-Jaldón
Marta Conde-Jaldón
JGJosé Raul García-Lozano
José Raul García-Lozano
LOLourdes Ortiz-Fernández
Lourdes Ortiz-Fernández
NONorberto Ortego-Centeno
Norberto Ortego-Centeno
MEMaria Francisca Gonza´laez Escribano
Maria Francisca Gonza´laez Escribano
Introduction: According to genome wide association (GWA) studies as well as candidate gene approaches, Behçet’s disease (BD) is associated with human leukocyte antigen (HLA)-A and HLA-B gene regions. The HLA-B51 has been consistently associated with the disease, but the role of other HLA class I molecules remains controversial. Recently, variants in non-HLA genes have also been associated with BD. The aims of this study were to further investigate the influence of the HLA region in BD and to explore the relationship with non-HLA genes recently described to be associated in other populations. Methods: This study included 304 BD patients and 313 ethnically matched controls. HLA-A and HLA-B low resolution typing was carried out by PCR-SSOP Luminex. Eleven tag single nucleotide polymorphisms (SNPs) located outside of the HLA-region, previously described associated with the disease in GWA studies and having a minor allele frequency in Caucasians greater than 0.15 were genotyped using TaqMan assays. Phenotypic and genotypic frequencies were estimated by direct counting and distributions were compared using the χ2 test. Results: In addition to HLA-B*51, HLA-B*57 was found as a risk factor in BD, whereas, B*35 was found to be protective. Other HLA-A and B specificities were suggestive of association with the disease as risk (A*02 and A*24) or protective factors (A*03 and B*58). Regarding the non-HLA genes, the three SNPs located in IL23R and one of the SNPs in IL10 were found to be significantly associated with susceptibility to BD in our population. Conclusion: Different HLA specificities are associated with Behçet’s disease in addition to B*51. Other non-HLA genes, such as IL23R and IL-10, play a role in the susceptibility to the disease.

15 January 2013 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JGJosé-Raúl García-Lozano
José-Raúl García-Lozano
BTBelén Torres-Agrela
Belén Torres-Agrela
MMMarco Antonio Montes-Cano
Marco Antonio Montes-Cano
LOLourdes Ortiz-Fernández
Lourdes Ortiz-Fernández
MCMarta Conde-Jaldón
Marta Conde-Jaldón
MEMaria Francisca Gonza´laez Escribano
Maria Francisca Gonza´laez Escribano
Introduction: AIRE is a transcriptional regulator playing a functional role in thymocyte education and negative selection by controlling the expression of peripheral antigens in the thymus. Recently, the AIRE gene was identified as a genetic risk factor for rheumatoid arthritis (RA) in genome wide association (GWA) studies performed in the Japanese population. According to the available data this association is restricted to the Asian population. However, different facts could influence the lack of association in Caucasian populations. The aim of this study was to further investigate the possible role of the AIRE gene in susceptibility to RA in a Caucasian population. Methods: A total of 472 Spanish Caucasian RA patients and 475 ethnically matched controls were included in the study. Three single-nucleotide polymorphisms (SNPs) (rs2776377, rs878081 and rs1055311) with a minor allele frequency >0.05 in the Caucasian population which were not included in the high-throughput platforms used in the GWA studies performed in susceptibility to RA, and two SNPs (rs2075876 and rs1800520) associated with RA in the Japanese population, were selected and genotyped using TaqMan assays. Results: No significant differences in the distribution of the alleles of rs2776377, rs2075876, rs1055311 and rs1800520 SNPs between RA patients and controls were observed. Nevertheless, the frequency of the C allele of rs878081 was significantly higher among RA patients (80.5% vs. 74.6% in the control group, pc = 0.012, OR = 1.41, 95%CI 1.13-1.75). Regarding the distribution of the rs878081 genotypes, a higher frequency of CC homozygous individuals was found in the RA patient group (65.56% vs. 56.47% in the control group, pc = 0.013, OR = 1.47, 95%CI 1.12-1.93). The in silico analysis predicted lower affinity to the binding-site of a motif of the transcription NF-κB family and lower transcription levels of AIRE gene for the rs878081C risk variant Conclusions: Our findings suggest that the AIRE gene is associated with susceptibility to RA in the Spanish population. Probably, this association has not been detected in the European population in the GWA studies because the earliest high-throughput platforms did not include SNP suitable markers (e.g. rs878081).

14 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMarta Conde-Jaldón
Marta Conde-Jaldón
MMMarco Antonio Montes-Cano
Marco Antonio Montes-Cano
JGJosé Raul García-Lozano
José Raul García-Lozano
LOLourdes Ortiz-Fernández
Lourdes Ortiz-Fernández
NONorberto Ortego-Centeno
Norberto Ortego-Centeno
MGMaría Francisca González-Escribano
María Francisca González-Escribano
Behçet's disease (BD) is a multifactorial disorder associated with the HLA region. Recently, the ERAP1 gene has been proposed as a susceptibility locus with a recessive model and with epistatic interaction with HLA-B51. ERAP1 trims peptides in the endoplasmic reticulum to optimize their length for MHC-I binding. Polymorphisms in this gene have been related with the susceptibility to other immune-mediated diseases associated to HLA class I. Our aim was, the replication in the Spanish population of the association described in the Turkish population between ERAP1 (rs17482078) and BD. Additionally, in order to improve the understanding of this association we analyzed four additional SNPs (rs27044, rs10050860, rs30187 and rs2287987) associated with other diseases related to HLA class I and the haplotype blocks in this gene region. According to our results, frequencies of the homozygous genotypes for the minor alleles of all the SNPs were increased among patients and the OR values were higher in the subgroup of patients with the HLA-B risk factors, although differences were not statistically significant. Moreover, the presence of the same mutation in both chromosomes increased the OR values from 4.51 to 10.72 in individuals carrying the HLA-B risk factors. Therefore, although they were not statistically significant, our data were consistent with an association between ERAP1 and BD as well as with an epistatic interaction between ERAP1 and HLA-B in the Spanish population.

16 December 2021 in Clinical and Experimental Rheumatology
Verified
Journal Article
Closed access
MPManuel Prados-Castaño
Manuel Prados-Castaño
MMMarco Antonio Montes-Cano
Marco Antonio Montes-Cano
RMRaquel Muñoz-Garcia
Raquel Muñoz-Garcia
JLJosé-Manuel Lucena-Soto
José-Manuel Lucena-Soto
MLMarina Labella-Álvarez
Marina Labella-Álvarez
MGMaria-Francisca González-Escribano
Maria-Francisca González-Escribano
Full Papers; Authors: M. Prados-Castaño, M.-A. Montes-Cano, R. Muñoz-Garcia, J.-M. Lucena-Soto, M. Labella-Álvarez, J.R. García-Lozano, M.-F. González-Escribano

18 June 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
RARocio Aguado
Rocio Aguado
JIJuan Irure-Ventura
Juan Irure-Ventura
MVMaria Luisa Vargas
Maria Luisa Vargas
GRGarbiñe Roy
Garbiñe Roy
Yvelise BarriosYvelise Barrios
Yvelise Barrios
Aurora Jurado RogerAurora Jurado Roger
Aurora Jurado Roger
Background/Objectives: Coeliac disease is an immune-mediated disorder of the gastrointestinal tract that may result in significant nutritional deficiencies. Effective management requires strict, lifelong adherence to a gluten-free diet. Both underdiagnosis and unnecessary dietary restrictions can adversely affect patients’ health and quality of life. To assess adherence to the current recommendations for the laboratory diagnosis of coeliac disease and promote evidence-based practices while reducing inter-laboratory variability, the Spanish Group on Autoimmunity of the Spanish Society of Immunology conducted a nationwide survey. Methods: A thirty-item survey was distributed to fifty autoimmune laboratories across Spain. Data were collected through a structured Excel-based questionnaire comprising multiple-choice items, which was distributed via email to the participating laboratories. It explored practices related to the diagnosis of coeliac disease in the general population and among at-risk groups as well as approaches to patient follow-up and demand management. Results: Thirty-five laboratories completed the electronic questionnaire. For the serological screening of coeliac disease, all the respondents reported using IgA anti-tissue transglutaminase (tTG-IgA) antibody testing together with total IgA measurement to assess IgA competence. However, consistent use of anti-endomysial antibody testing and HLA genotyping and adherence to pre-analytical recommendations for accurate interpretation of results were not uniform across centres. Conclusions: At the time these data were collected (the third trimester of 2021), the 2020 ESPGHAN guidelines for the diagnosis of coeliac disease in the paediatric population had not yet been fully implemented in most of the laboratories surveyed. For diagnosing adults, most laboratories adhered to local and European guidelines.